Sources | Names Used |
---|---|
GDSC1000, GRAY, FIMM | Bortezomib |
gCSI, CTRPv2 | bortezomib |
PharmacoGx | Bortezomib |
Database | Identifier |
---|---|
Smiles: | B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O |
Inchikey: | GXJABQQUPOEUTA-RDJZCZTQSA-N |
Pubchem: | 387447 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TLR3 | FIMM | pan-cancer | AAC | 0.43 | 0.007 |
mRNA | SREBF2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
mRNA | HMGN4 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.007 |
mRNA | ARMCX2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
mRNA | LAMA2 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.007 |
mRNA | RABGGTA | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |
mRNA | ITPK1 | FIMM | pan-cancer | AAC | -0.38 | 0.007 |
mRNA | TMEM2 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.007 |
mRNA | NPEPL1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
mRNA | CD163 | gCSI | pan-cancer | AAC | -0.15 | 0.007 |